Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: A mechanism including AMPKα1/SIRT

Journal of Lipid Research

Volumn 55, Issue 3, 2014, Pages 363-374

  Dong, Jing ^a   Zhang, Xian ^a   Zhang, Lei ^a   Bian, Hui Xi ^a   Xu, Na ^a   Bao, Bin ^a   Liu, Jian ^a  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE 1ALPHA; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; QUERCETIN; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE MACROPHAGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C57BL 6 MOUSE; CELL INFILTRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPIDIDYMIS FAT; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; OBESITY; POLARIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WEIGHT REDUCTION;

ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE Α1/SILENT INFORMATION REGULATOR 1; ADIPOSE TISSUE MACROPHAGE; INSULIN RESISTANCE; MACROPHAGES; OBESITY;

3T3-L1 CELLS; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; EPIDIDYMIS; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 4; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PHOSPHORYLATION; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIRTUIN 1; WEIGHT GAIN;

EID: 84894815681     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M038786     Document Type: Article

References (55)

1. Sun, S., Y. Ji, S. Kersten, and L. Qi. 2012. Mechanisms of inflammatory responses in obese adipose tissue. Annu. Rev. Nutr. 32: 261-286.
2. Ouchi, N., J. L. Parker, J. J. Lugus, and K. Walsh. 2011. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11: 85-97.
3. Osborn, O., and J. M. Olefsky. 2012. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18: 363-374.
4. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184. (Pubitemid 46048464)
5. Patsouris, D., P. P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels. 2008. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8: 301-309.
6. Panchal, S. K., H. Poudyal, and L. Brown. 2012. Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J. Nutr. 142: 1026-1032.
7. Kobori, M., S. Masumoto, Y. Akimoto, and Y. Takahashi. 2009. Dietary quercetin alleviates diabetic symptoms and reduces strep-tozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 53: 859-868.
8. Ahn, J., H. Lee, S. Kim, J. Park, and T. Ha. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 373: 545-549.
9. Yang, L., X. F. Li, L. Gao, Y. O. Zhang, and G. P. Cai. 2012. Suppressive effects of quercetin-3-O-(6″-Feruloyl)-beta-D-galactopyranoside on adipogenesis in 3T3-L1 preadipocytes through down-regulation of PPARgamma and C/EBPalpha expression. Phytother. Res. 26: 438-444.
10. Overman, A., C. C. Chuang, and M. McIntosh. 2011. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage- conditioned media. Int. J. Obes. (Lond). 35: 1165-1172.
11. Comalada, M., I. Ballester, E. Bailon, S. Sierra, J. Xaus, J. Galvez, F. S. de Medina, and A. Zarzuelo. 2006. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol. 72: 1010-1021. (Pubitemid 44374465)
12. Hämäläinen, M., R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen. 2007. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007: 45673.
13. Puangpraphant, S., and E. G. de Mejia. 2009. Saponins in yerba mate tea (Ilex paraguariensis A. St.-Hil) and quercetin synergistically inhibit iNOS and COX-2 in lipopolysaccharide-induced macrophages through NFkappaB pathways. J. Agric. Food Chem. 57: 8873-8883.
14. Chuang, C. C., W. Shen, H. Chen, G. Xie, W. Jia, S. Chung, and M. K. McIntosh. 2012. Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fatfed obese mice. J. Agric. Food Chem. 60: 12458-12468.
15. Chuang, C. C., K. Martinez, G. Xie, A. Kennedy, A. Bumrungpert, A. Overman, W. Jia, and M. K. McIntosh. 2010. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr. 92: 1511-1521.
16. Stewart, L. K., Z. Wang, D. Ribnicky, J. L. Soileau, W. T. Cefalu, and T. W. Gettys. 2009. Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia. 52: 514-523.
17. Wein, S., N. Behm, R. K. Petersen, K. Kristiansen, and S. Wolffram. 2010. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur. J. Pharm. Sci. 41: 16-22.
18. Stewart, L. K., J. L. Soileau, D. Ribnicky, Z. Q. Wang, I. Raskin, A. Poulev, M. Majewski, W. T. Cefalu, and T. W. Gettys. 2008. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism. 57: S39-S46. (Pubitemid 351814697)
19. Boesch-Saadatmandi, C., A. E. Wagner, S. Wolffram, and G. Rimbach. 2012. Effect of quercetin on inflammatory gene expression in mice liver in vivo-role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol. Res. 65: 523-530.
20. Kobori, M., S. Masumoto, Y. Akimoto, and H. Oike. 2011. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol. Nutr. Food Res. 55: 530-540.
21. Zhou, M., S. Wang, A. Zhao, K. Wang, Z. Fan, H. Yang, W. Liao, S. Bao, L. Zhao, Y. Zhang, et al. 2012. Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice. J. Proteome Res. 11: 4961-4971.
22. Kim, J. H., M. J. Kang, H. N. Choi, S. M. Jeong, Y. M. Lee, and J. I. Kim. 2011. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr. Res. Pract. 5: 107-111.
23. Rivera, L., R. Moron, M. Sanchez, A. Zarzuelo, and M. Galisteo. 2008. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring). 16: 2081-2087.
24. Jeong, S. M., M. J. Kang, H. N. Choi, J. H. Kim, and J. I. Kim. 2012. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr. Res. Pract. 6: 201-207.
25. Ying, H. Z., Y. H. Liu, B. Yu, Z. Y. Wang, J. N. Zang, and C. H. Yu. 2013. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food Chem. Toxicol. 52: 53-60.
26. Marcolin, E., B. San-Miguel, D. Vallejo, J. Tieppo, N. Marroni, J. Gonzalez-Gallego, and M. J. Tunon. 2012. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J. Nutr. 142: 1821-1828.
27. Weng, S. Y., and D. Schuppan. 2013. AMPK regulates macrophage polarization in adipose tissue inflammation and NASH. J. Hepatol. 58: 619-621.
28. Salminen, A., J. M. Hyttinen, and K. Kaarniranta. 2011. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. (Berl). 89: 667-676.
29. Yang, Z., B. B. Kahn, H. Shi, and B. Z. Xue. 2010. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 285: 19051-19059.
30. Sag, D., D. Carling, R. D. Stout, and J. Suttles. 2008. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181: 8633-8641.
31. Escande, C., V. Nin, N. L. Price, V. Capellini, A. P. Gomes, M. T. Barbosa, L. O'Neil, T. A. White, D. A. Sinclair, and E. N. Chini. 2013. Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 62: 1084-1093.
32. Kellenberger, E., I. Kuhn, F. Schuber, and H. Muller-Steffner. 2011. Flavonoids as inhibitors of human CD38. Bioorg. Med. Chem. Lett. 21: 3939-3942.
33. Howitz, K. T., K. J. Bitterman, H. Y. Cohen, D. W. Lamming, S. Lavu, J. G. Wood, R. E. Zipkin, P. Chung, A. Kisielewski, L. L. Zhang, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425: 191-196. (Pubitemid 37150899)
34. Liu, J., A. Divoux, J. Sun, J. Zhang, K. Clement, J. N. Glickman, G. K. Sukhova, P. J. Wolters, J. Du, C. Z. Gorgun, et al. 2009. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15: 940-945.
35. Altintas, M. M., A. Azad, B. Nayer, G. Contreras, J. Zaias, C. Faul, J. Reiser, and A. Nayer. 2011. Mast cells, macrophages, and crownlike structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 52: 480-488.
36. Lee, W. H., R. J. Lin, S. Y. Lin, Y. C. Chen, H. M. Lin, and Y. C. Liang. 2011. Osthole enhances glucose uptake through activation of AMP-activated protein kinase in skeletal muscle cells. J. Agric. Food Chem. 59: 12874-12881.
37. Wang, L., E. Trebicka, Y. Fu, L. Waggoner, S. Akira, K. A. Fitzgerald, J. C. Kagan, and B. J. Cherayil. 2011. Regulation of lipopolysac-charide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM. J. Innate Immun. 3: 437-446.
38. Cheng, Z., T. Pang, M. Gu, A. H. Gao, C. M. Xie, J. Y. Li, F. J. Nan, and J. Li. 2006. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim. Biophys. Acta. 1760: 1682-1689. (Pubitemid 44667275)
39. Yang, M., Y. Zhang, J. Pan, J. Sun, J. Liu, P. Libby, G. K. Sukhova, A. Doria, N. Katunuma, O. D. Peroni, et al. 2007. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat. Cell Biol. 9: 970-977. (Pubitemid 47190452)
40. Huang, S., and M. P. Czech. 2007. The GLUT4 glucose transporter. Cell Metab. 5: 237-252. (Pubitemid 46477860)
41. Leto, D., and A. R. Saltiel. 2012. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat. Rev. Mol. Cell Biol. 13: 383-396.
42. Park, H. H., S. Lee, H. Y. Son, S. B. Park, M. S. Kim, E. J. Choi, T. S. Singh, J. H. Ha, M. G. Lee, J. E. Kim, et al. 2008. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res. 31: 1303-1311.
43. Kempuraj, D., M. L. Castellani, C. Petrarca, S. Frydas, P. Conti, T. C. Theoharides, and J. Vecchiet. 2006. Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin. Exp. Med. 6: 150-156. (Pubitemid 46025589)
44. Chalkiadaki, A., and L. Guarente. 2012. High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 16: 180-188.
45. Carling, D., M. J. Sanders, and A. Woods. 2008. The regulation of AMP-activated protein kinase by upstream kinases. Int. J. Obes. (Lond). 32(Suppl. 4): S55-S59.
46. Galic, S., M. D. Fullerton, J. D. Schertzer, S. Sikkema, K. Marcinko, C. R. Walkley, D. Izon, J. Honeyman, Z. P. Chen, B. J. van Denderen, et al. 2011. Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 121: 4903-4915.
47. Anhê, G. F., M. M. Okamoto, A. Kinote, C. Sollon, C. Lellis-Santos, F. F. Anhe, G. A. Lima, S. M. Hirabara, L. A. Velloso, S. Bordin, et al. 2012. Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur. J. Pharmacol. 689: 285-293.
48. Rickard, A. J., and M. J. Young. 2009. Corticosteroid receptors, macrophages and cardiovascular disease. J. Mol. Endocrinol. 42: 449-459.
49. Neves, A. L., J. Coelho, L. Couto, A. Leite-Moreira, and R. Roncon-Albuquerque, Jr. 2013. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J. Mol. Endocrinol. 51: R51-R64.
50. Olefsky, J. M., and C. K. Glass. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72: 219-246.
51. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
52. Leiherer, A., A. Mundlein, and H. Drexel. 2013. Phytochemicals and their impact on adipose tissue inflammation and diabetes. Vascul. Pharmacol. 58: 3-20.
53. Jiang, S., W. Wang, J. Miner, and M. Fromm. 2012. Cross regulation of sirtuin 1, AMPK, and PPARgamma in conjugated linoleic acid treated adipocytes. PLoS ONE. 7: e48874.
54. Prieur, X., C. Y. Mok, V. R. Velagapudi, V. Nunez, L. Fuentes, D. Montaner, K. Ishikawa, A. Camacho, N. Barbarroja, S. O'Rahilly, et al. 2011. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 60: 797-809.
55. Cantó, C., Z. Gerhart-Hines, J. N. Feige, M. Lagouge, L. Noriega, J. C. Milne, P. J. Elliott, P. Puigserver, and J. Auwerx. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 458: 1056-1060.